Renaissance Technologies »

Acrivon Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $734k 103k 7.15

More positions owned by Renaissance Technologies

Novo-nordisk A S Adr (NVO)
Palantir Technologies Cl A (PLTR)
Meta Platforms Cl A (META)
Airbnb Com Cl A (ABNB)
Amazon (AMZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Verisign (VRSN)
Uber Technologies (UBER)
NVIDIA Corporation (NVDA)
United Therapeutics Corporation (UTHR)
Chipotle Mexican Grill (CMG)
Franco-Nevada Corporation (FNV)
CBOE Holdings (CBOE)
Exelixis (EXEL)
Crowdstrike Hldgs Cl A (CRWD)

View all positions for Renaissance Technologies

Top funds holding Acrivon Therapeutics

RA Capital Management
Perceptive Advisors
Citadel Advisors
Sands Capital Ventures
Wellington Management Company
BlackRock
Marshall Wace
Vanguard Group
Geode Capital Management
State Street Corporation
DAFNA Capital Management
UBS O'Connor
Northern Trust
Renaissance Technologies
Millennium Management

View all funds holding Acrivon Therapeutics